Literature DB >> 33031566

Maternal body mass index and risk of obstetric, maternal and neonatal outcomes: A cohort study of nulliparous women with spontaneous onset of labor.

Rebecka Dalbye1, Nina Gunnes2, Ellen Blix3, Jun Zhang4, Torbjørn Eggebø5,6, Linn Nistov Tokheim7, Pål Øian8, Stine Bernitz1,3.   

Abstract

INTRODUCTION: This study investigates associations between maternal body mass index (BMI) early in pregnancy and obstetric interventions, maternal and neonatal outcomes.
MATERIAL AND METHODS: This is a cohort study of nulliparous women originally included in a cluster randomized controlled trial carried out at 14 Norwegian obstetric units between 2014 and 2017. The sample included 7189 nulliparous women with a singleton fetus, cephalic presentation and spontaneous onset of labor at term, denoted as group 1 in the Ten-Group Classification System. The women were grouped according to the World Health Organization BMI classifications: underweight (BMI <18.5), normal weight (BMI 18.5-24.9), pre-obesity (BMI 25.0-29.9), obesity class I (BMI 30.0-34.9), and obesity classes II and III (BMI ≥35.0). We used binary logistic regression to estimate crude and adjusted odds ratios (ORs) of the interventions and outcomes, with associated 95% confidence intervals (CIs), comparing women in different BMI groups with women of normal weight.
RESULTS: We found an increased risk of intrapartum cesarean section in women of obesity class I and obesity classes II and III, with adjusted OR of 1.70 (95% CI 1.21-2.38) and 2.31 (95% CI 1.41-3.77), respectively. Women in obesity groups had a gradient of risk of epidural analgesia and use of continuous CTG (including STAN), with adjusted OR of 2.39 (95% CI 1.69-3.38) and 3.28 (95% CI 1.97-5.48), respectively. Women in obesity classes II and III had higher risk of amniotomy (adjusted OR = 1.42, 95% CI 1.02-1.96), oxytocin augmentation (adjusted OR = 1.54, 95% CI 1.11-2.15), obstetric anal sphincter injuries (adjusted OR = 2.21, 95% CI 1.01-4.85) and postpartum hemorrhage ≥1000 mL (adjusted OR = 2.20, 95% CI 1.29-3.78). We found a reduced likelihood of spontaneous vaginal delivery for pre-obese women (adjusted OR = 0.85, 95% CI 0.74-0.97) and no associations between maternal BMI and neonatal outcomes.
CONCLUSIONS: Obese women in Ten-Group Classification System group 1 had increased risks of obstetric interventions and maternal complications. There was a gradient of risk for intrapartum cesarean section, with the highest risk for women in obesity classes II and III. No associations between maternal BMI and neonatal outcomes were observed.
© 2020 Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Ten-Group Classification System; body mass index; cesarean section; maternal outcome; neonatal outcome; nulliparous; obstetric interventions; postpartum hemorrhage

Mesh:

Year:  2020        PMID: 33031566     DOI: 10.1111/aogs.14017

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

Review 1.  Overweight, obesity and excessive weight gain in pregnancy as risk factors for adverse pregnancy outcomes: A narrative review.

Authors:  Simon C Langley-Evans; Jo Pearce; Sarah Ellis
Journal:  J Hum Nutr Diet       Date:  2022-03-20       Impact factor: 2.995

Review 2.  Early life programming of health and disease: The long-term consequences of obesity in pregnancy.

Authors:  Simon C Langley-Evans
Journal:  J Hum Nutr Diet       Date:  2022-05-10       Impact factor: 2.995

3.  Association between Maternal Origin, Pre-Pregnancy Body Mass Index and Caesarean Section: A Nation-Wide Registry Study.

Authors:  Fatou Jatta; Johanne Sundby; Siri Vangen; Benedikte Victoria Lindskog; Ingvil Krarup Sørbye; Katrine Mari Owe
Journal:  Int J Environ Res Public Health       Date:  2021-06-01       Impact factor: 3.390

4.  Leptin-Induced HLA-G Inhibits Myometrial Contraction and Differentiation.

Authors:  Maeva Wendremaire; Tatiana E Lopez; Marina Barrichon; Hang Zhang; Tarik Hadi; Xiang-Yang Ye; Fabrice Neiers; Marc Bardou; Paul Sagot; Carmen Garrido; Frédéric Lirussi
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.